Eagle Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-151,268
Closed -$9.41M 626
2023
Q4
$9.41M Sell
151,268
-5,920
-4% -$331K 0.05% 278
2023
Q3
$8.82M Sell
157,188
-217,157
-58% -$12.2M 0.05% 279
2023
Q2
$18.9M Sell
374,345
-11,354
-3% -$604K 0.11% 193
2023
Q1
$21M Buy
385,699
+22,018
+6% +$1.29M 0.12% 159
2022
Q4
$21.7M Buy
363,681
+8,958
+3% +$594K 0.13% 163
2022
Q3
$25M Buy
354,723
+249,443
+237% +$17.2M 0.16% 152
2022
Q2
$5.97M Sell
105,280
-155
-0.1% -$8.5K 0.04% 324
2022
Q1
$6.6M Sell
105,435
-4,748
-4% -$256K 0.03% 344
2021
Q4
$6.19M Sell
110,183
-13,576
-11% -$830K 0.03% 376
2021
Q3
$8.05M Sell
123,759
-16,120
-12% -$1.1M 0.04% 350
2021
Q2
$8.87M Sell
139,879
-5,443
-4% -$321K 0.04% 347
2021
Q1
$8.52M Buy
145,322
+12,664
+10% +$689K 0.04% 354
2020
Q4
$6.62M Buy
132,658
+77,735
+142% +$3.65M 0.04% 350
2020
Q3
$2.71M Buy
+54,923
New +$2.29M 0.01% 418

Other funds holding AXNX

Eagle Asset Management's AXNX Position: Q1 2024 in Review

Eagle Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 151,268 shares — an estimated $9.41M sold.

Eagle Asset Management first reported a position in AXNX in Q3 2020 and held it in 14 quarters. The position peaked at $25M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Eagle Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 151,268 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $9.41M.
  • Eagle Asset Management first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Eagle Asset Management's Axonics, Inc. Common Stock position peaked at $25M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.